Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines

Vaccine

Volumn 32, Issue 13, 2014, Pages 1423-1430

  Pobre, Karl ^a   Tashani, Mohamed ^a,b   Ridda, Iman ^a,b   Rashid, Harunor ^a   Wong, Melanie ^a   Booy, Robert ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antibody response; Carrier priming; Conjugate vaccine; Polysaccharide vaccine

Indexed keywords

CHORIONIC GONADOTROPIN VACCINE; DIPHTHERIA TOXOID; DRUG CARRIER; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MALARIA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; DATA BASE; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VACCINATION;

ANTIBODY RESPONSE; CARRIER PRIMING; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE;

ANIMALS; ANTIBODY FORMATION; BACTERIAL CAPSULES; DRUG CARRIERS; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES; VACCINES, CONJUGATE;

EID: 84896739369     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.047     Document Type: Review

References (75)

1. Watt J.P., Wolfson L.J., O'Brien K.L., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009, 374(September (9693)):903-911. [PubMed PMID: 19748399. Epub 2009/09/15.eng].
2. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(September (9693)):893-902. [PubMed PMID: 19748398. Epub 2009/09/15.eng].
3. Trotter C.L., Andrews N.J., Kaczmarski E.B., Miller E., Ramsay M.E. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004, 364(July (9431)):365-367. [PubMed PMID: 15276396. Epub 2004/07/28.eng].
4. Finn A., Heath P. Conjugate vaccines. Arch Dis Child 2005, 90(July (7)):667-669. [PubMed PMID: 15970605. Pubmed Central PMCID: PMC1720496.English].
5. Avery O.T., Goebel W.F. Chemo-immunological studies on conjugated carbohydrate-proteins: II. Immunological specificity of synthetic sugar-protein antigen. J Exp Med 1929, 50(September (4)):533-550. [PubMed PMID: 19869645. Pubmed Central PMCID: 2131643. Epub 1929/09/30.eng].
6. Rappuoli R., De Gregorio E. A sweet T cell response. Nat Med 2011, 17(December (12)):1551-1552. [PubMed PMID: 22146455. Epub 2011/12/08.eng].
7. Avci F.Y., Li X., Tsuji M., Kasper D.L. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 2011, 17(12):1602-1609.
8. Lee L.H., Blake M.S. Effect of increased CRM197 carrier protein dose on meningococcal C bactericidal antibody response. Clin Vaccine Immunol 2012, 19(April (4)):551-556.
9. Kurikka S. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy. Vaccine 1996, 14(September (13)):1239-1242. [PubMed PMID: 8961512. Epub 1996/09/01.eng].
10. Granoff D.M., Holmes S.J., Osterholm M.T., McHugh J.E., Lucas A.H., Anderson E.L., et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993, 168(September (3)):663-671. [PubMed PMID: 8354908. Epub 1993/09/01.eng].
11. Delves P.J., Martin S.J., Burton D.R., Roitt I.M. Roitt's essential immunology 2011, Wiley-Blackwell, West Sussex, UK.
12. Schutze M.P. Carrier-induced epitopic suppression is initiated through clonal dominance. J Immunol 1989, 142(8):2635.
13. Schutze M.P., Leclerc C., Jolivet M., Audibert F., Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol 1985, 135(4):2319-2322.
14. Giudice G.D. New carriers and adjuvants in the development of vaccines. Curr Opin Immunol 1992, 4(4):454-459.
15. Pöllabauer E.M., Petermann R., Ehrlich H.J. The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants. Vaccine 2009, 27(11):1674-1679.
16. Peeters C.C., Tenbergen-Meekes A.M., Poolman J.T., Beurret M., Zegers B.J., Rijkers G.T. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun 1991, 59(October (10)):3504-3510. [PubMed PMID: 1894357. Pubmed Central PMCID: 258913].
17. Schneerson R., Robbins J.B., Chu C., Sutton A., Vann W., Vickers J.C., et al. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun 1984, 45(September (3)):582-591. [PubMed PMID: 6332076. Pubmed Central PMCID: 263334. Epub 1984/09/01.eng].
18. Anderson P. Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect Immun 1983, 39(January (1)):233-238.
19. Vella P.P., Ellis R.W. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. Pediatr Res 1991, 29(January (1)):10-13. [PubMed PMID: 2000253. Epub 1991/01/01.eng].
20. Schneerson R., Barrera O., Sutton A., Robbins J.B. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 1980, 152(August (2)):361-376. [PubMed PMID: 6967514. Pubmed Central PMCID: 2185954. Epub 1980/08/01.eng].
21. Katz D.H., Paul W.E., Goidl E.A., Benacerraf B. Carrier function in anti-hapten immune responses I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med 1970, 132(August (2)):261-282. [PubMed PMID: 4101344. Pubmed Central PMCID: 2138738.].
22. Stickings P., Peyre M., Coombes L., Muller S., Rappuoli R., Del Giudice G., et al. Transcutaneous immunization with cross-reacting material CRM197 of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine. Infect Immun 2008, 76(April (4)):1766-1773.
23. Granoff D.M., Holmes S.J., Belshe R.B., Osterholm M.T., McHugh J.E., Anderson E.L. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 1994, 272(October (14)):1116-1121. [PubMed PMID: 7933324].
24. Parke J.C., Schneerson R., Reimer C., Black C., Welfare S., Bryla D., et al. Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age. J Pediatr 1991, 118(2):184-190.
25. Barington T., Gyhrs A., Kristensen K., Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994, 62(January (1)):9-14. [PubMed PMID: 8262653. Pubmed Central PMCID: 186060. Epub 1994/01/01.eng].
26. Kayhty H., Eskola J., Peltola H., Ronnberg P.R., Kela E., Karanko V., et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child 1991, 145(February (2)):223-227. [PubMed PMID: 1994693. Epub 1991/02/01.eng].
27. Castillo de Febres O., Decker M., Estopinan M., Bordones G., Edwards K. Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 1994, 13(7):635.
28. Granoff D.M., Rathore M.H., Holmes S.J., Granoff P.D., Lucas A.H. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Vaccine 1993, Suppl. 1:S46-S51.
29. Kurikka S. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy. Vaccine 1996, 14(13):1239-1242.
30. Kurikka S., Käyhty H., Saarinen L., Rönnberg P.-R., Eskola J., Mäkelä P.H. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995, 172(5):1268-1272.
31. Decker M.D., Edwards K.M., Bradley R., Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992, 120(2(Part 1)):184-189.
32. Lagos R., Valenzuela M.T., Levine O.S., Losonsky G.A., Erazo A., Wasserman S.S., et al. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998, 351(May (9114)):1472-1476. [PubMed PMID: 9605803. Epub/05/30.eng].
33. Anderson P., Pichichero M., Edwards K., Porch C.R., Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine. J Pediatr 1987, 111(5):644-650.
34. Anderson P., Pichichero M., Insel R. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. J Clin Invest 1985, 76(1):52.
35. Campagne G., Garba A., Schuchat A., Boulanger D., Plikaytis B.D., Ousseini M., et al. Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey Niger. Am J Trop Med Hyg 1998, 59(November (5)):837-842.
36. Granoff O.M., Holmes S.J., Belshe R.B. The effect of carrier priming on the anticapsular (PRP) antibody responses to Haemophilus influenzae type b (Hib) conjugate vaccines. Pediatr Res 1993, 169A:33. [Abstract].
37. Guimarães T., Cereda R.F., Bianchin P.J., Nagao A.T., Sampaio M.C., Mendonça J.S. Antibody response to Haemophilus influenzae type b tetanus conjugate vaccine with two doses given at 3 and 5 months of age. Int J Infect Dis 2002, 6(2):113-117.
38. Booy R., Heath P.T., Slack M.P.E., Begg N., Richard Moxon E. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997, 349(9060):1197-1202.
39. Lieberman J.M., Greenberg D.P., Wong V.K., Partridge S., Chang S.J., Chiu C.Y., et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 1995, 126(February (2)):198-205. [PubMed PMID: 6657844].
40. Sangpetchsong V., Impat A., Dhiensiri K., Podhipak A. Effect of passive immunity to tetanus in DTP vaccinated infants. Southeast Asian J Trop Med Public Health 1985, 16(1):117.
41. Booy R., Taylor S., Tudor-Williams G., Moxon E.R., Aitken S.J.M., Griffiths H., et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 1992, 339(8792):507-510.
42. Mulholland K., Suara R.O., Siber G., Roberton D., Jaffar S., N'Jie J., et al. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the Gambia. JAMA 1996, 275(15):1182-1188. [PubMed PMID: 8609686. Epub/04/17.eng].
43. Sarvas H., Kurikka S., Seppälä I.J.T., Mäkelä P.H., Mäkelä O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis 1992, 165(5):977-979.
44. Claesson B.A., Schneerson R., Robbins J.B., Johansson J., Lagergard T., Taranger J., et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr 1989, 114(1):97-100.
45. Scheifele D.W., Halperin S.A., Smith B., Ochnio J., Meloff K., Duarte-Monteiro D. Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate DTaP, IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. Vaccine 2006, 24(12):2057-2064.
46. Givon-Lavi N., Greenberg D., Dagan R. Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial. Pediatr Infect Dis J 2010, 29(8):756-762.
47. Spijkerman J., Veenhoven R.H., Wijmenga-Monsuur A.J., et al. Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial. JAMA 2013, 310(9):930-937.
48. Lucero M.G., Puumalainen T., Ugpo J.M., Williams G., Käyhty H., Nohynek H. Similar antibody concentrations in filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial. J Infect Dis 2004, 189(11):2077-2084.
49. Burrage M., Robinson A., Borrow R., Andrews N., Southern J., Findlow J., et al. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun 2002, 70(September (9)):4946-4954.
50. Weston W.M., Friedland L.R., Wu X., Howe B. Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration. Vaccine 2011, 29(5):1017-1022.
51. ® full prescribing information 2011 2011, http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm70.pdf.1311.
52. Arguedas A., Soley C., Loaiza C., Rincon G., Guevara S., Perez A., et al. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines. Vaccine 2010, 28(18):3171-3179.
53. McVernon J., MacLennan J., Clutterbuck E., Buttery J., Moxon E.R. Effect of infant immunisation with meningococcus serogroup C-CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children. Vaccine 2003, 21(19-20):2573-2579.
54. Barington T., Kristensen K., Henrichsen J., Heilmann C. Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1991, 59(3):1057-1064.
55. Barington T., Sparholt S., Juul L., Heilmann C. A simplification of the enzyme-linked immunospot technique increased sensitivity for cells secreting IgG antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol Methods 1992, 156(2):191-198.
56. Barington T., Skettrup M., Juul L., Heilmann C. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infect Immun 1993, 61(2):432-438.
57. Goldblatt D., Southern J., Andrews N., Ashton L., Burbidge P., Woodgate S., et al. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infect Dis 2009, 49(9):1318-1325.
58. Shelly M.A., Pichichero M.E., Treanor J.J. Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scand J Infect Dis 2001, 33(7):542-544.
59. Ölander R.-M., Wuorimaa T., Käyhty H., Leroy O., Dagan R., Eskola J. Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers. Vaccine 2001, 20(3):336-341.
60. Di John D., Wasserman S.S., Torres J.R., Cortesia M.J., Murillo J., Losonsky G.A., et al. Effect of priming with carrier on response to conjugate vaccine. Lancet 1989, 2(December (8677)):1415-1418. [PubMed PMID: 499 2480].
61. Shah S., Raghupathy R., Singh O., Talwar G.P., Sodhi A. Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine. Vaccine 1999, 17(23-24):3116-3123.
62. Knuf M., Kowalzik F., Kieninger D. Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine 2011, 29(31):4881-4890.
63. Hurme M., Kontiainen S., Seppälä I.J.T., Mäkelä O. Affinity and Ig classes of anti-hapten antibodies in carrier-preimmunized rats. Eur J Immunol 1973, 3(4):191-195.
64. Ishizaka K. Reaginic antibody formation in the mouse II. Enhancement and suppression of anti-hapten antibody formation by priming with carrier. J Immunol 1973, 110(4):1067.
65. Lagos R., Valenzuela M.T., Levine O.S., Losonsky G.A., Erazo A., Wasserman S.S., et al. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998, 351(9114):1472-1476.
66. Booy R. Getting Hib vaccine to those who need it. Lancet 1998, 351(9114):1446-1447.
67. Knuf M., Schmitt H.-J., Wolter J., Schuerman L., Jacquet J.-M., Kieninger D., et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008, 152(5):655-660.
68. Siegrist C.-A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(24):3406-3412.
69. Barington T., Gyhrs A., Kristensen K., Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994, 62(1):9-14.
70. Kurikka S., Käyhty H., Peltola H., Saarinen L., Eskola J., Mäkelä P.H. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics 1995, 95(6):815-822.
71. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902.
72. Richmond P., Borrow R., Miller E., Clark S., Sadler F., Fox A., et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis 1999, 179(6):1569-1572.
73. Sarvas H., MÄKelÄ O., Toivanen P., Toivanen A. Effect of carrier preimmunization on the anti-hapten response in the chicken. Scand J Immunol 1974, 3(4):455-460.
74. Ahman H. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998, 17(3):211-216.
75. Baraldo K., Mori E., Bartoloni A., Petracca R., Giannozzi A., Norelli F., et al. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines. Infect Immun 2004, 72(8):4884-4887.